Combined intensive immunosuppression and eculizumab for aplastic anemia in the context of hemolytic paroxysmal nocturnal hemoglobinuria: a retrospective analysis

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2018-01, Vol.53 (1), p.105-107
Hauptverfasser:	Pagliuca, S, Risitano, A M, De Fontbrune, F S, Robin, M, Iori, A P, Marotta, S, Michonneau, D, Villate, A, Desmier, D, Socié, G, De Latour, R P
Format:	Artikel
Sprache:	eng
Schlagworte:	692/699/1541 692/699/1541/13 Adult Aged Analysis Anemia Anemia, Aplastic - drug therapy Anemia, Aplastic - pathology Antibodies, Monoclonal, Humanized - pharmacology Antibodies, Monoclonal, Humanized - therapeutic use Aplastic anemia Care and treatment Cell Biology Complications and side effects Dosage and administration Eculizumab Hematology Hemoglobinuria, Paroxysmal - drug therapy Hemoglobinuria, Paroxysmal - pathology Humans Immunosuppression Immunosuppression - methods Internal Medicine letter-to-the-editor Medicine Medicine & Public Health Monoclonal antibodies Paroxysmal nocturnal hemoglobinuria Physiological aspects Public Health Retrospective Studies Stem cell transplantation Stem Cells Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!